Shanghai Huaota Biopharmaceutical Co., Ltd.

This early-stage trial tests a new drug called HB0043 in 15 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and abscesses. The drug targets two inflammatory proteins to potentially control the disease. The main goal is to c…

This early-stage study is testing whether a new drug, HB0056, is safe and tolerable in healthy adults. About 46 volunteers will receive a single dose of the drug or a placebo. Researchers will monitor for side effects and measure how the drug moves through the body. This study do…